Bevacizumab and erlotinib versus bevacizumab for colorectal cancer treatment: systematic review and meta-analysis

Kaveh, S; Ebrahimi, P; Rezapour, A; Mozafari, M; Sayehmiri, K

Sayehmiri, K (reprint author), Ilam Univ Med Sci, Prevent Ctr Social Mental Injuries, Ilam, Iran.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019; 41 (1): 30

Abstract

Background Improving the survival of patients diagnosed with metastatic colorectal cancer requires the use of chemotherapy to be managed with minimum ......

Full Text Link